Background

• Coronavirus disease (COVID-19) pandemic has caused more than 330,000 death and serious health problem world-wide
• Early detection of the infection is important
• Population immunity needs to check accurately
• Quick detection method for cases with early infection and population-wide screening for immunity is needed
• Cross-reactivity of antibody in the present commercially available detection methods is a problem

Technology Overview

• Unique novel targets to SARS-CoV-2
• Clearly distinguish between infected cases and normal control when compared with Protein S
• Make use of luciferase immunoprecipitation system